JPAG - serving its members since 1970
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control and registration.
Great value, highly-relevant meetings presented by recognised leading experts in their field
Powerful networking opportunities
Superb and highly convenient locations
Non-profit professional organisation means lower delegate fees
JPAG is a "not-for-profit" organisation run for
pharmaceutical analysts by
Our only sponsors are our parent professional bodies, the Royal Pharmaceutical Society and the Royal Society of Chemistry. NEXT EVENTS:
6th February 2014Developments in analysis of orally inhaled and nasal drug productsRoyal Society of Chemistry, London
This symposium will provide delegates working in the analysis, development or regulation of orally inhaled and nasal drug products with an update on recent developments in the field.
20th March 2014Annual General Meeting of JPAGRoyal Society of Chemistry, London
The 44th Annual General Meeting of the Group will be held before the Group symposium and will commence at 9.30 a.m.
Please note that you are able to attend the AGM (only) without registering for the symposium.
20th March 2014Pharmaceutical equivalence, therapeutic equivalence and the role of analytical scienceRoyal Society of Chemistry, London
The assumption that pharmaceutical equivalence predicts therapeutic equivalence is becoming increasingly contested. The greater complexity of medicinal products and their global sourcing .challenge this belief. Have you been following this important discussion? Do you know and understand what important developments in the scientific and regulatory frameworks are taking place? Are you aware of the implications for the safe use of medicines?
15th May 2014Combating counterfeit medicines: a major and growing challenge to patient safety. Going globalRoyal Society of Chemistry, London
Counterfeit medicines - or more appropriately - fake medicines pose great dangers to society. Regrettably fake medicines are not a new phenomenon. What is new, however, is the recent global escalation of both counterfeit prescriptions and consumer healthcare products.
This symposium provides a current and strategic overview of how industry and regulatory authorities in Europe and the US are addressing the rapidly growing counterfeiting challenge.
11th December 2013JPAG symposium: Dissolution of inhaled products: in vitro developments, in vivo relevance and the potential impact on regulatory thinkingEdinburgh International Conference Centre LAST EVENT:
JPAG half-day symposium in association with the Drug Delivery to the Lungs 24
annual conference organised by The Aerosol Society.
The panel of speakers;: Sau Lee, U.S FDA; Sabine May, PharmBioTec, Sarbrucken, Germany; Rob Price, University of Bath; and Robyn Sadler, GSK
29th October 2013High concentration biologics: Viscosity, characterisation and deliveryFitzwilliam College, Cambridge University
3rd Annual MIBio Conference, organised by the Formulation Science and Technology Group (FSTG) of the Royal Society Chemistry (RSC) and the Academy of Pharmaceutical Scientists (APS)
Good speakers with a real flare and enthusiasm for their work, making the presentations very interesting [March 2012]
Overall it was a useful course and nice connection to the science and the advances in pharmaceutical analysis [March 2012]
Good venue and well organised – thanks [May 2012]
An enjoyable day [May 2012]
The facilities and refreshments/food were EXCELLENT – thank you [May 2012]
Very good symposium – many thanks [May 2012]
This was a very useful meeting with a wide range of interesting presentations [March 2013]
Good venue, good organisation [May 2013]
Most of the speakers made a general and quite useful introduction which allowed everyone to follow the presentation no matter the level; it was really easy to reach the location [May 2013]
I thought the symposium was very well balanced to cover all aspects of stability – hence it was all very useful [July 2013]
Good, well-organised and attended day, relevant presentations, interesting comments and discussion [July 2013]
Excellent venue, very good speakers and overall topics highly applicable [July 2013]
Excellent day; very fruitful discussions with new acquaintances [October 2013]
Venue, facilities and lunch were very good [October 2013]
Good variety of topics and delegates [October 2013]
Length of presentations ideal; catering excellent – thanks [October 2013]
ICHQ3D Metal Impurities. A critical evaluation
JPAG presents the fourth in a series what has become a regular feature on this page.
The article is entitled "ICHQ3D Metal Impurities. A critical evaluation", written by Dr Andy Teasdale, AZ and Chairman of JPAG, and Dr Dave Elder, GSK, mem...More...2nd November 2013
The JPAG Geoffrey Phillips Analytical Science Award.
Dr Jonathan Moffat, University of East Anglia, who was the 2012 winner of the JPAG Geoffrey Phillips Analytical Science Award received a bursary of £1,000 to attend the International Symposium on Pharmaceutical and Biomedical Analysis 2013 in B...More...22nd August 2013
Delegates who attended any of the symposia this year can access the speakers presentations.
Just SIGN IN, go to RESOURCES and look for MY PAST MEETINGS:
"Assuring the quality of medicines"
Thursday 7 February
"Progress and challenges in pharmaceutical harmonisation"
Thursday 21 March
"New approaches in bio-analysis and analytical toxicology”
Thursday 16 May
"Meeting stability challenges”
Thursday 4 July
"ICH Q3D (Metals Guidelines): Opportunities and challenges"
Thursday 10 October
Missed the meeting?
You can access a short report of recent meetings!
Just go to the MEETINGS page, go to PAST MEETINGS 2011-present.
Then select the DETAILS for the meeting that interests you.
And be sure to check the list of upcoming meetings so that you don't miss the next one!
European Pharmaceutical Review
JPAG members can receive a free hard copy subscription to EPRclick here
However, it does securely hold details for those who register an account.
This information is only used by JPAG as described in the Privacy Statement (see link on footer below).